Humana Divests Gentiva Minority Interest

Humana Inc. has announced a definitive agreement to divest all or substantially all of its minority interest in Gentiva Health Services, a leading provider of end-of-life services, for approximately $900 million. This transaction is a continuation of Humana's strategy to divest non-core businesses, which began with its acquisition of Kindred at Home in 2021 and the subsequent divestiture of a majority interest in Kindred at Home's Hospice and Personal Care divisions to Clayton, Dubilier & Rice in 2022, leading to the rebranding as Gentiva Health Services. The sale is expected to close in the third quarter of 2026, subject to regulatory approvals, and Humana plans to use the proceeds for general corporate purposes without anticipating a material impact on its 2026 earnings. Guggenheim Partners, Fried, Frank, Harris, Shriver & Jacobson LLP, and Manatt, Phelps & Phillips LLP are advising Humana on the transaction.